Related Experiment Video

Updated: Aug 6, 2026

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus
09:53

An In Vitro Model for Studying Cellular Transformation by Kaposi Sarcoma Herpesvirus

Published on: August 25, 2017

Current therapeutic options for Kaposi's sarcoma

D I Abrams1

  • 1University of California, San Francisco 94110, USA.

Oncology (Williston Park, N.Y.)
|June 1, 1996
PubMed

Insights

Treatment options for acquired immune deficiency syndrome (AIDS)-related Kaposi

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Acquired immune deficiency syndrome (AIDS)-related Kaposi's sarcoma (KS) treatment options have seen minimal advancement over the last decade.
  • Research progress is hindered by the lack of a standardized KS staging system and uniform response criteria.
  • Understanding KS pathogenesis, including angiogenesis and growth factors, is crucial for future therapeutic development.

Purpose of the Study:

  • To review current treatment modalities for AIDS-related Kaposi's sarcoma.
  • To highlight challenges in KS research and identify areas for future therapeutic innovation.
  • To emphasize the need for improved survival outcomes beyond palliative care for AIDS-related KS.

Main Methods:

  • Review of existing literature on AIDS-related Kaposi's sarcoma treatments.
  • Discussion of current therapeutic options: radiation therapy, chemotherapy, and biologic response modifiers.
  • Exploration of potential improvements in drug delivery systems for chemotherapy.

Main Results:

  • Current treatment landscape for AIDS-related KS remains largely unchanged.
  • Existing therapies include radiation, chemotherapy, and biologic response modifiers.
  • Potential for improved chemotherapy efficacy and reduced side effects through advanced delivery systems.

Conclusions:

  • There is a critical need to recommit research efforts towards improving survival rates for patients with AIDS-related KS.
  • Future therapies may benefit from a deeper understanding of KS pathogenesis, particularly angiogenesis.
  • Focus should shift from purely cosmetic or palliative treatments to enhancing patient survival.

More Related Videos

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)07:02

Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus (KSHV)

Published on: September 14, 2010

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus07:10

Establishment and Quantification of De Novo Lytic Infection by Cell-free Kaposi's Sarcoma-Associated Herpesvirus

Published on: August 15, 2025

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...